公开(公告)号：US20190241601A1

公开(公告)日：2019-08-08

申请号：US16343307

申请日：2017-10-16

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong-Deog HONG ,  Minsik CHOI ,  Si Young CHO ,  Jeong-Kee KIM

IPC: C07H17/07

Abstract: The present specification relates to a novel quercetin-based compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.

公开(公告)号：US20210275422A1

公开(公告)日：2021-09-09

申请号：US16336749

申请日：2017-09-26

Applicant: AMOREPACIFIC CORPORATION

Inventor： Juewon KIM ,  Minsik CHOI ,  Yong Deog HONG ,  Siyoung CHO

IPC: A61K8/49 ,  A61Q19/00 ,  A23L33/00 ,  A23L33/10

Abstract: The present specification describes an anti-stress composition containing, as an active ingredient, cosmoperine, an isomer thereof, a pharmaceutically or cosmetically acceptable salt thereof, a hydrate thereof or a solvate thereof. The composition can alleviate or relieve physical and psychological symptoms caused by stress.

公开(公告)号：US20210322452A1

公开(公告)日：2021-10-21

申请号：US16340753

申请日：2017-10-16

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong-Deog HONG ,  Minsik CHOI ,  Si Young CHO ,  Jeong-Kee KIM

IPC: A61K31/7048 ,  A61K36/82 ,  A61P25/28 ,  A23L33/00 ,  A23L33/105 ,  A23L2/52

Abstract: The present specification relates to a cognitive function decrease improving composition comprising a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in fields related to cognitive functions and nerve cell protection.

公开(公告)号：US20190284223A1

公开(公告)日：2019-09-19

申请号：US16340920

申请日：2017-10-12

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong-Deog HONG ,  Minsik CHOI ,  Si Young CHO ,  Jeong-Kee KIM

IPC: C07H17/07 ,  C12P19/60

Abstract: The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.